methandrostenolone
Small moleculeexperimental
Metandienone is an orally active synthetic anabolic-androgenic steroid. In 1970, the FDA accepted that Metandienone (Dianabol) was “Probably Effective” in treating post-menopausal osteoporosis and pituitary-deficient dwarfism. Methandrostenolone is still produced today, but typically in nations with loose prescription drug regulations and by companies that still prefer to cater to an underground athletic market. Androgenic side effects are still common with this substance. This may include bouts of oily skin, acne, and body/facial hair growth. Anabolic/androgenic steroids may also aggravate male pattern hair loss. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Chemistry & pharmacology
Loading structure…
SMILES
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C- Mol. weight
- 300.4351 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMetandienone ↗
- NCATSCOZ1R7EOCC ↗
- ChEMBLCHEMBL1418176 ↗
Also known as
- dehydromethyltestosterone
- metanabol
- metandienon
- metandienonum
- metandrostenolon
- metandrostenolone
- methandrolone
- methandrostenolone
- methandrostenolone
- methandrostenolone
- methandrostenolone
- methandrostenolone
- methandrostenolone
- methylboldenone